Cocrystal Pharma, Inc. (COCP) Tops Q3 EPS by 12c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.41), $0.12 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Wells Fargo sees machinery sector recovery shifting to demand-driven
• Beam Global reports Q2 2026 revenue above $8.5M, up 170% from Q1